Swiss National Bank - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 151 filers reported holding ANIKA THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 1.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$605,475
-26.0%
32,500
+3.2%
0.00%
-100.0%
Q2 2023$818,370
-9.5%
31,5000.0%0.00%0.0%
Q1 2023$904,680
-13.2%
31,500
-10.5%
0.00%0.0%
Q4 2022$1,041,920
+28.0%
35,200
+2.9%
0.00%0.0%
Q3 2022$814,000
+6.7%
34,2000.0%0.00%0.0%
Q2 2022$763,000
-11.2%
34,2000.0%0.00%
Q1 2022$859,000
-24.6%
34,200
+7.5%
0.00%
-100.0%
Q4 2021$1,139,000
-15.8%
31,8000.0%0.00%0.0%
Q3 2021$1,353,000
-0.1%
31,800
+1.6%
0.00%0.0%
Q2 2021$1,355,000
+2.2%
31,300
-3.7%
0.00%0.0%
Q1 2021$1,326,000
-8.2%
32,500
+1.9%
0.00%0.0%
Q4 2020$1,444,000
+27.9%
31,9000.0%0.00%0.0%
Q3 2020$1,129,000
-6.2%
31,9000.0%0.00%0.0%
Q2 2020$1,204,000
+50.3%
31,900
+15.2%
0.00%0.0%
Q1 2020$801,000
-41.5%
27,700
+4.9%
0.00%0.0%
Q4 2019$1,369,000
-5.5%
26,4000.0%0.00%
-50.0%
Q3 2019$1,449,000
+35.2%
26,4000.0%0.00%
+100.0%
Q2 2019$1,072,000
+39.0%
26,400
+3.5%
0.00%0.0%
Q1 2019$771,000
-10.0%
25,5000.0%0.00%0.0%
Q4 2018$857,000
-20.4%
25,5000.0%0.00%0.0%
Q3 2018$1,076,000
+31.9%
25,5000.0%0.00%0.0%
Q2 2018$816,000
-35.6%
25,5000.0%0.00%
-50.0%
Q1 2018$1,268,000
-3.2%
25,500
+4.9%
0.00%
+100.0%
Q4 2017$1,310,000
-7.0%
24,3000.0%0.00%
-50.0%
Q3 2017$1,409,000
+17.5%
24,3000.0%0.00%
+100.0%
Q2 2017$1,199,000
+13.5%
24,3000.0%0.00%0.0%
Q1 2017$1,056,000
-11.3%
24,3000.0%0.00%
-50.0%
Q4 2016$1,190,000
+10.5%
24,300
+8.0%
0.00%0.0%
Q3 2016$1,077,000
-17.4%
22,500
-7.4%
0.00%0.0%
Q2 2016$1,304,000
+29.8%
24,300
+4.3%
0.00%0.0%
Q1 2016$1,005,000
+39.4%
23,300
+23.3%
0.00%0.0%
Q4 2015$721,000
+19.8%
18,9000.0%0.00%0.0%
Q3 2015$602,000
+11.1%
18,900
+15.2%
0.00%
+100.0%
Q2 2015$542,000
-19.7%
16,4000.0%0.00%
-50.0%
Q1 2015$675,000
+6.1%
16,400
+5.1%
0.00%0.0%
Q4 2014$636,000
+11.2%
15,6000.0%0.00%0.0%
Q3 2014$572,000
-20.9%
15,6000.0%0.00%
-33.3%
Q2 2014$723,000
+19.7%
15,600
+6.1%
0.00%
+50.0%
Q1 2014$604,000
+40.1%
14,700
+30.1%
0.00%0.0%
Q4 2013$431,00011,3000.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Trigran Investments, Inc. 1,154,183$25,761,0003.00%
CAPITAL MANAGEMENT CORP /VA 275,130$6,141,0001.52%
Kent Lake Capital LLC 98,570$2,200,0001.21%
DIKER MANAGEMENT LLC 21,835$487,0000.60%
Portolan Capital Management 235,972$5,267,0000.53%
Riverwater Partners LLC 12,466$278,0000.28%
Ranger Investment Management 139,661$3,117,0000.24%
Invenomic Capital Management LP 144,287$3,220,0000.23%
CHATHAM CAPITAL GROUP, INC. 23,787$531,0000.12%
Teton Advisors, Inc. 22,000$491,0000.10%
View complete list of ANIKA THERAPEUTICS INC shareholders